For Clinical Development, Translational Research & AI
ABPath-certified and GMC-registered pathologists delivering end-to-end pathology expertise for clinical development and AI.
Trusted experience across pharmaceutical, academic and AI research organisations
Pathology Nucleus is a consultant-led network of credentialled pathologists delivering expertise in translational pathology, biomarker development and AI-enabled tissue analysis for pharmaceutical and biotechnology organisations.
We integrate directly with client teams or deliver as an independent external partner, working remotely to enable flexible, scalable collaboration without the need for on-site infrastructure.
Our network spans a broad range of pathology subspecialties, enabling comprehensive coverage across therapeutic areas and study types.
Clinical scientists support workflow coordination and scalable delivery, while pathologists retain full responsibility for scientific interpretation, diagnostic judgement and quality oversight.
UK General Medical Council recognised specialists
American Board of Pathology certified, internationally recognised
Supporting scalable delivery and efficient project coordination
Pathologist-led evaluation of AI models and expert annotation for clinical and regulatory use
Tissue-based biomarker expertise across oncology and clinical development programmes
Independent central review for clinical trials, endpoint adjudication and regulatory submission
ABPath certified and GMC specialist registered pathologists with expertise in clinical development, translational research and AI-enabled pathology.
A collaborative network of subspecialist pathologists covering the full range of diagnostic and translational pathology disciplines.
Deep expertise in whole slide imaging, digital pathology platforms and AI-driven pathology workflows developed through direct collaboration with AI teams.
A network of subspecialist pathologists supported by clinical scientists, enabling scalable workflows and efficient project delivery with pathologist-led oversight at every stage.
Trusted by pharmaceutical and biotechnology organisations across biomarker research, clinical trials and AI development programmes.
Direct collaboration with pathologists delivering your project, enabling clear scientific discussion and efficient decision making from scoping through to delivery.
Whether you need diagnostic consultation, AI annotation expertise or central review for a clinical study, we would like to hear from you.